(Reuters) – Abbott Laboratories said on Monday it has entered into an agreement with the U.S. Food and Drug Administration on the steps necessary to resume production and maintain its baby formula facility at Sturgis, Michigan.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Amy Caren Daniel)
